USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: TRANSGENOMIC, INC.
Address: 12325 Emmet Street
Omaha, NE 68164-4268
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (240) 631-2001

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $99,353.00 1
STTR Phase I $400,000.00 3

Award List:

The Molecular Culture

Award Year / Program / Phase: 2004 / STTR / Phase I
Agency: HHS
Research Institution: MAYO CLINIC COLL OF MEDICINE, ROCHESTER
Principal Investigator: George Hong
Award Amount: $100,000.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): In the clinical setting, molecular microbiologic detection methods have classically focused on a single microorganism or a small group of microorganisms. Broad range molecular detection of bacteria in clinical specimens is an approach that parallels a… More

SBIR Phase I: Surveyor Endonuclease Adaptor-Ligated Libraries for Genomic Mutation Analysis

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: NSF
Principal Investigator: Gary F. Gerard, BS
Award Amount: $99,353.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project develops a novel process allowing rapid and cost-effective analysis of genetic variation between test and known, control genomes. The method, known as SEAL, will allow researchers to construct DNA libraries containing only these… More

Early Detection of Pancreatic Cancer Using Ice COLD-PCR

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF NEBRASKA MEDICAL CENTER
Principal Investigator: Grant Wu – 402-452-5416
Award Amount: $100,000.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Ninety percent of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). PDAC diagnosis is difficult, usually occurring in the late stages of disease. Patients with these advanced tumors typically respondpoorly to therapy. Post diagnosis, median… More

Temperature-Tolerant COLD-PCR enables mutation-enriched targeted re-sequencing

Award Year / Program / Phase: 2013 / STTR / Phase I
Agency: HHS
Research Institution: DANA-FARBER CANCER INSTITUTE
Principal Investigator: Katherine A. Richardson – 402-452-5416
Award Amount: $200,000.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Cancers develop from the life-long accumulation of critical somatic mutations due to DNA-damaging agents that lead to cells transforming into tumor-forming cells. These low-level tumor-associated somatic DNA mutations can have profound implications for… More